These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 23264619)
1. Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2). Hughes CE; Sinha U; Pandey A; Eble JA; O'Callaghan CA; Watson SP J Biol Chem; 2013 Feb; 288(7):5127-35. PubMed ID: 23264619 [TBL] [Abstract][Full Text] [Related]
2. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. Fuller GL; Williams JA; Tomlinson MG; Eble JA; Hanna SL; Pöhlmann S; Suzuki-Inoue K; Ozaki Y; Watson SP; Pearce AC J Biol Chem; 2007 Apr; 282(17):12397-409. PubMed ID: 17339324 [TBL] [Abstract][Full Text] [Related]
3. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets. Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Pollitt AY; Grygielska B; Leblond B; Désiré L; Eble JA; Watson SP Blood; 2010 Apr; 115(14):2938-46. PubMed ID: 20154214 [TBL] [Abstract][Full Text] [Related]
7. Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity. Rückrich T; Steinle A J Biol Chem; 2013 Jun; 288(24):17725-33. PubMed ID: 23609447 [TBL] [Abstract][Full Text] [Related]
8. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766 [TBL] [Abstract][Full Text] [Related]
9. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets. Kostyak JC; Mauri B; Dangelmaier C; Vari HR; Patel A; Wright M; Reddy H; Tsygankov AY; Kunapuli SP J Biol Chem; 2022 Aug; 298(8):102189. PubMed ID: 35753354 [TBL] [Abstract][Full Text] [Related]
11. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development. Lee RH; Bergmeier W J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528 [TBL] [Abstract][Full Text] [Related]
12. The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets. Hughes CE; Finney BA; Koentgen F; Lowe KL; Watson SP Blood; 2015 Jan; 125(1):144-54. PubMed ID: 25352128 [TBL] [Abstract][Full Text] [Related]
13. The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk). Bauer B; Wotapek T; Zöller T; Rutkowski E; Steinle A J Biol Chem; 2017 Feb; 292(8):3213-3223. PubMed ID: 28082678 [TBL] [Abstract][Full Text] [Related]
14. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β. Moroi AJ; Watson SP J Thromb Haemost; 2015 Jun; 13(6):1139-50. PubMed ID: 25858425 [TBL] [Abstract][Full Text] [Related]
15. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460 [TBL] [Abstract][Full Text] [Related]
16. The platelet receptor CLEC-2 is active as a dimer. Watson AA; Christou CM; James JR; Fenton-May AE; Moncayo GE; Mistry AR; Davis SJ; Gilbert RJ; Chakera A; O'Callaghan CA Biochemistry; 2009 Nov; 48(46):10988-96. PubMed ID: 19824697 [TBL] [Abstract][Full Text] [Related]
18. GPVI and CLEC-2 in hemostasis and vascular integrity. Watson SP; Herbert JM; Pollitt AY J Thromb Haemost; 2010 Jul; 8(7):1456-67. PubMed ID: 20345705 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Bu JY; Shaw AS; Chan AC Proc Natl Acad Sci U S A; 1995 May; 92(11):5106-10. PubMed ID: 7761456 [TBL] [Abstract][Full Text] [Related]
20. The structure of CLEC-2: mechanisms of dimerization and higher-order clustering. Martin EM; Zuidscherwoude M; Morán LA; Di Y; García A; Watson SP Platelets; 2021 Aug; 32(6):733-743. PubMed ID: 33819136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]